血清癌胚抗原趋势在FACS随机临床试验中诊断结直肠癌复发的价值
该研究基于FACS试验(2003-2014)分析CEA趋势对结直肠癌复发的诊断准确性,采用时间依赖ROC曲线比较趋势与单次测量的效能。结论认为解读CEA趋势可提高诊断准确性,但不足以作为单一监测策略,应结合临床、内镜和影像学监测。
要点
- 无单一趋势阈值敏感性超过70%,不能单独用于触发检查。
核心结论
- 解读CEA趋势比单次测量可提高复发诊断准确性,但不足以作为单一监测策略。
- 在缺乏更准确生物标志物时,CEA趋势监测应结合临床、内镜和影像学监测。
研究设计与样本
- 基于FACS随机临床试验(2003-2014)的分析,评估CEA趋势对结直肠癌复发的诊断准确性。
- 采用时间依赖ROC曲线分析比较CEA趋势与单次测量的诊断准确性,CEA趋势用线性回归估计。
主要发现
- 无单一趋势阈值敏感性超过70%,即30%复发被漏诊。
关键数值与推荐
- CEA水平至少高于基线7 μg/l时触发进一步检查以检测复发。
临床怎么用
- 临床监测结直肠癌复发时,应关注CEA的动态趋势而非单次测量值。
- CEA趋势监测需与临床症状、结肠镜和CT等影像学监测联合使用以提高准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most guidelines recommend that patients who have undergone curative resection for primary colorectal cancer are followed up for 5 years with regular blood carcinoembryonic antigen (CEA) tests to trigger further investigation for recurrence. However, CEA may miss recurrences, or patients may have false alarms and undergo unnecessary investigation. METHODS: The diagnostic accuracy of trends in CEA measurements for recurrent colorectal cancer, taken as part of the FACS (Follow-up After Colorectal Surgery) trial (2003-2014), were analysed. Investigation to detect recurrence was triggered by clinical symptoms, scheduled CT or colonoscopy, or a CEA level of at least 7 μg/l above baseline. Time-dependent receiver operating characteristic (ROC) curve analysis was used to compare the diagnostic accuracy of CEA trends with single measurements. CEA trends were estimated using linear regression. RESULTS: The area under the ROC curve (AUC) for CEA trend was at least 0·820 across all 5 years of follow-up. In comparison, the AUCs for single measurements ranged from 0·623 to 0·749. Improvement was most marked at the end of the first year of follow-up, with the AUC increasing from 0·623 (95 per cent c.i. 0·509 to 0·736) to 0·880 (0·814 to 0·947). However, no individual trend threshold achieved a sensitivity above 70 per cent (30 per cent missed recurrences). CONCLUSION: Interpreting trends in CEA measurements instead of single CEA test results improves diagnostic accuracy for recurrence, but not sufficiently to warrant it being used as a single surveillance strategy to trigger further investigation. In the absence of a more accurate biomarker, monitoring trends in CEA should be combined with clinical, endoscopic and imaging surveillance for improved accuracy.
引用
- Shinkins B, Primrose JN, Pugh SA, et al. Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial. Br J Surg. 2018. PMID: 29579327. doi:10.1002/bjs.10819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。